10x Genomics: T. Rowe Price reports 14.5% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
10x Genomics, Inc. (TXG) shares are the subject of T. Rowe Price Associates, Inc.'s amended ownership report. As of September 30, 2026, T. Rowe Price Associates reported beneficial ownership of 17,472,941 shares, or 14.5% of the class, with sole voting power over 16,779,529 shares and sole dispositive power over 17,472,941 shares. The entity expressly stated that the report is not an admission that it is the beneficial owner of the securities.
Key Figures
Key Terms
beneficial ownership financial
sole voting power financial
sole dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.